Tempo para acesso ao tratamento do câncer de mama no Distrito Federal, Brasil Central

PURPOSE: To analyze the time between the first symptom and treatment in patients treated for breast cancer in public hospitals in the Federal District. METHODS: This was a cross-sectional analysis. We interviewed 250 women diagnosed with breast cancer treated in six hospitals of the State Department of Health of the Federal District from November 2009 to January 2011. The time intervals studied were the time between the detection of the symptoms and treatment subdivided into intervals until and after the first medical appointment. The variables were: age, menopausal status, color, educational level, average monthly household income, origin, reason for the initial consultation, staging, tumor size, laterality, metastasis to axillary lymph nodes, neoadjuvant chemotherapy, and type of surgery. The Mann-Whtney test was used to assess the association of these variables with the time intervals until treatment. RESULTS: The mean age was 52 years, with a predominance of white women (57.6%), from the Federal District (62.4%), with a family income of up to 2 minimum wages (78%), and up to four years of schooling (52.4%). The staging of the disease ranged from II to IV in 78.8% of the women. The time between the first symptom and treatment was 229 days (median). After detection of the first symptom, 52.9% of the women attended a consultation within 30 days and 88.8% took more than 90 days to start treatment. Women with elementary school education had a greater delay to the start of treatment (p=0.049). CONCLUSIONS: There was a significant delay to start treatment of women with breast cancer in public hospitals of the Federal District, suggesting that efforts should be made to reduce the time needed to schedule medical appointments and to diagnose and treat these patients.

Mapas topográficos: metadados e as regras de catalogação para o acesso eficiente à informação geográfica

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Embalagens de medicamentos: diretrizes para o desenvolvimento

Pós-graduação em Design - FAAC

O canal de retorno na TV digital e as estratégias para universalização do acesso a Internet

Pós-graduação em Televisão Digital: Informação e Conhecimento - FAAC

Acesso remoto seguro de experimentação em tempo real

Pós-graduação em Engenharia Elétrica - FEIS

A representação da informação do documento de arquivo: perspectivas metodológicas para elaboração de pontos de acesso

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Vale a pena ver de novo - organização e acesso a arquivos televisivos na França, Grã-Bretanha e no Brasil

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Representação e Persistência para acesso a Recursos Informacionais Digitais gerados dinamicamente em sítios oficiais do Governo Federal

The Information Access law, sanctioned in November 18, 2011, regulates the constitutional right of access to public information by Brazilian citizens. Although this law requires the provision of information of public interest, it does not define how such information should be made available. Ideally, information should be in an open format, allowing its use in an efficient and fast way. In the official sites of the federal government the way information is currently available does not allow its reuse as they are presented in dynamic pages from the selection parameters and filters. The objective aim of this paper is to present the system called MDDIR Tool, which proposes ways to persist, represent and retrieve digital information resources generated by the Federal Government official sites. Although this system had been designed for a specific purpose, it may be applied to other fields with similar characteristics. The purpose is to facilitate the access to open data, allowing such data to be consolidated and organized , generating new knowledge and information easy to be interpreted by the general population.

Acesso à informação geográfica: reflexões sobre a importância das Infraestruturas de Dados Espaciais (IDE) nas políticas públicas

This article discusses the access to geographic information and its importance for the public policies formulation, reflecting on the implementation of the Spatial Data Infrastructure. The data view and the maps construction are useful for identifying needs and sponsoring public managers in decision making. The public policies implementation stages are optimized when the quantitative and qualitative information are integrated to the spatial phenomena relations. The improvement in the use of geographic information for decision making will be achieved when spatial data are efficiently generated in spatial data infrastructures.

Arquivo e literatura: perspectivas de acesso e difusão da memória literária no Brasil

Besides storing, the culture and science institutions in charge of the of Brazilian writers’ personal archives play such an important role on the organization and representation of the country’s literary information. In general, the target public for these collections is composed by researchers from the field of Literature once the documents produced by the writers throughout his/her life and career constitute primary research source for the artistic, historical and literary investigation. However, it is still convenient to stand out those users with no academic instruction, whose interest in such collections is justified by their looking up to the individual. In this sense, literary memory places, such as the Brazilian Literature Archive Museum – AMLB (RJ) -, the Brazilian Literature Academy – ABL – (RJ) and the Brazilian Studies Institute – IEB – (SP) turn out to be responsible for offering access to the literary archives and literary information. Thus, it is necessary to consider that databases demonstrate themselves as utter disseminators of the preservation and diffusion of the literary memory, coming up with several possibilities for cultural and scientific action in Literature. This study focuses on showing the contributions of databases towards the literary archives, the challenges and perspectives observed according to the mentioned institutions’ reality, in whose missions the discourse of the literary memory preservation is inserted.

A produção institucional na perspectiva arquivística: Lei de Acesso à Informação e aproximações

This study regards the implementation of the Law of Access to Information, from an archivistic perspective of the institutional production of recorded projects in the period 1992- 2012 at the Letters and Arts Center (LAC) of the Federal University of Santa Maria (UFSM) and stored on digital medium in its database. It concludes that the effects of the law of access to information, as related to the institutional production by UFSM, will bring benefits to all society.

Análise de notificação B em uma drogaria de Araraquara e avaliação do conhecimento dos prescritores quanto à legislação vigente

Uma das diretrizes da Portaria nº3916 do Ministério da Saúde (MS) é a Relação Nacional de Medicamentos Essenciais (RENAME). A prescrição de medicamentos dentro do Sistema Único de Saúde (SUS) deve ser feita utilizando medicamentos listados nessa relação. O medicamento genérico, criado e regulamentado pela Lei nº9787, é prioridade da Política Nacional de Medicamentos do MS. De acordo com esta lei, “as prescrições médicas e odontológicas de medicamentos, no âmbito do Sistema Único de Saúde – SUS adotarão obrigatoriamente a Denominação Comum Brasileira (DCB)”. A Portaria 344/98 MS, que regulamenta o controle dos medicamentos sujeitos a controle especial, determina os itens que devem estar presentes nas notificações. Neste trabalho, 1177 notificações retidas em uma drogaria de Araraquara durante o período de junho de 2008 a outubro de 2010 foram separadas e analisadas quanto: a) à utilização da DCB; b) quanto à utilização de medicamentos listados na RENAME; e c) quanto à adequação a Portaria 344/98 MS. Também foi avaliado o conhecimento dos prescritores quanto às leis vigentes através da aplicação de um questionário semiestruturado. Entre as 1177 notificações analisadas, 779 (66,18%) foram prescritas utilizando o nome comercial e 398 (33,82%) foram prescritas utilizando a DCB. Analisando as 399 notificações vindas do SUS, 188 (47,11%) adotaram os medicamentos da RENAME. Foram encontrados 319 problemas com as notificações de acordo com a Portaria 344/98 MS, os quais foram: 22 (1,86%) notificações com algum erro na identificação do emitente e/ou assinatura do prescritor; 3 (0,25%) notificações com algum erro na identificação do usuário; 294 (24,97%) notificações com preenchimento confuso nos itens como nome do medicamento ou substância, dosagem ou concentração, forma farmacêutica , quantidade e posologia; e 465 (39,50%)... (Resumo completo, clicar acesso eletrônico abaixo)

Avaliação do potencial efeito cicatrizante gástrico e antiartrítico da mangiferina, uma xantona glicosilada da Mangifera indica

Rheumatoid arthritis (RA) is a chronic illness with great potential to cause comorbidities resulting from cumulative inflammatory activities, and it contributes with the increase of disabilities and death of patients. It affects 1 to 2% of world population and usually occurs between 30 and 50 years of age. Among existing therapeutic options for the disease non-steroidal anti-inflammatory drugs (NSAIDs) still play an important part in the treatment, being widely used by patients to relieve pain and stiffness. However, this class of drugs causes many adverse gastrointestinal effects, such as dyspepsia, heartburn, nausea and vomit, and its use is one of the most common causes of peptic ulcers. Mangiferin (a glicosilated xanthone extracted mainly from the bark of Mangifera indica L.) is the main compound of an aqueous extract made from the bark stem of the mango tree. Previous studies conducted by our research group prove the anti-inflammatory action of mangiferin on an animal model of periodontitis, and its gastroprotective action has been described before. Considering these informations this study evaluated mangiferin’s potential on the treatment of RA and on gastric ulcer healing in animal models, and analyzed toxicity parameters to assure efficacy and safety of the compound as potential new drug for the treatment of the disease. RA was induced in rats by subcutaneous injection of bovine collagen and Freund’s complete adjuvant. This method presented low incidence of RA in rats, but we were able to induce the disease in 60 to 70% of the animals. Due to the wide use of NSAIDs and its potential to cause peptic ulcers, we induced gastric ulcer on arthritic rats to analyze mangiferin’s gastric healing effect. After 14 days of treatment we noticed small increase of the lesion area of animals treated with mangiferin or ibuprofen, when compared to the animals... (Complete abstract click electronic access below)

Avaliação da qualidade de comprimidos de captopril 50 mg comercializados no Brasil

O captopril foi o primeiro agente desenvolvido para o tratamento da hipertensão, doença que acomete grande parte da população adulta mundial, a qual requer cuidados especiais quanto à farmacoterapia e ajuste de doses. Assim sendo, este trabalho tem como objetivo avaliar a qualidade de comprimidos de captopril 50 mg comercializados no Brasil através da realização da equivalência farmacêutica entre duas marcas de comprimidos não revestidos de captopril 50 mg (um genérico G e um similar S) em relação ao medicamento referência (R) Capoten® Bristol Myers Squibb 50 mg, utilizando os requisitos descritos na monografia individual do fármaco da Farmacopeia Brasileira e da Farmacopeia Americana. Medicamentos referência são produtos inovadores, cuja eficácia, segurança e qualidade foram comprovadas cientificamente; os chamados similares são os que contêm as mesmas substâncias ativas, mesma concentração, forma farmacêutica, via de administração, posologia e indicação terapêutica do medicamento de referência e são identificados por nome comercial ou por sua marca; os medicamentos genéricos são intercambiáveis com o produto referência e, geralmente, são produzido após a expiração ou renúncia da proteção patentária do mesmo, ele deve ser designado pela DCB (Denominação Comum Brasileira) ou, na ausência desta, pela DCI (Denominação Comum Internacional). Os dois medicamentos analisados, medicamento similar e medicamento genérico, apresentaram resultados satisfatórios quanto à determinação de peso médio, resistência mecânica e tempo de desintegração dos comprimidos, identificação, doseamento, limite de dissulfeto de captopril, uniformidade de doses unitárias, teste de dissolução e perfil de dissolução do fármaco, com relação ao seu medicamento referência correspondente, ou seja, estes são equivalentes farmacêuticos e apresentam qualidade... (Resumo completo, clicar acesso eletrônico abaixo)

Eventos adversos em terapia medicamentosa em Unidade de Terapia Intensiva - UTI

Due to the complexity and instability of clinical conditions of ICU patients, the drug therapy applied in this type of environment requires a combination of several prescribed drugs, which is a favorable condition for drug interaction, toxic synergism and possible iatrogenia. In the possible universe of ICU occurrences, this study aimed at identifying and evaluating the incidence of adverse events in drug therapy at the Intensive Care Therapy Service (SETI) in wards I and II. It is a cross-sectional, descriptive, prospective and quantitative study conducted from August to September, 2011 in the Intensive Care Service of the Botucatu School of Medicine University Hospital - UNESP. The population consisted of fifteen clinical nurses, including those in the Improvement and Volunteer Internship Programs, who contributed to the investigation after signing an informed consent form and according to approval by the Research Ethics Committee number 10711/CE - FMB. The data were entered on a form and analyzed. Results showed that, on average, 8.9% of events/day occurred, and the highest frequency was observed on August 04, 2011. 63% and 22% were respectively observed in the morning and afternoon shifts, and 15% in the night shift. 48% of these were due to administration time errors, followed by drug prescription and dispensation errors, with percentages of 22% and 18%, respectively. Antibiotics showed the highest frequency of adverse events - 18%, which was followed by 13% for anticoagulant, 11% for antiemetic and 10% for antiulcerative drugs. As regards the occurrence of adverse events related to hospitalization time, the highest frequency occurred in patients who were hospitalized for 10 days. Concerning the ratio between reported events and the number of items in the prescription, the highest frequency of events was related to prescriptions with 20 items... (Complete abstract click electronic access below)